These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 364713)

  • 1. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL; Loyd B; Cohen MH
    Surg Forum; 1977; 28():158-9. PubMed ID: 364713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 4. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
    Dworski M
    Am Rev Respir Dis; 1973 Aug; 108(2):294-300. PubMed ID: 4578541
    [No Abstract]   [Full Text] [Related]  

  • 7. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors.
    Peters LC; Brandhorst JS; Hanna MG
    Cancer Res; 1979 Apr; 39(4):1353-60. PubMed ID: 217533
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P; Mathews HL
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative active-specific immunotherapy of lymph node micrometastasis in a guinea pig tumor model.
    Bier H; Armonat G; Bier J; Schirrmacher V; Ganzer U
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(4):197-205. PubMed ID: 2664632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A technique for intensifying BCG sensitivity.
    Parmett SR; Klein E
    J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early administration of isoniazid on the immunizing activity of normal BCG and isoniazid-resistant BCG in guinea pigs.
    BRETEY J; CANETTI G
    Am Rev Tuberc; 1957 Apr; 75(4):650-5. PubMed ID: 13411424
    [No Abstract]   [Full Text] [Related]  

  • 15. Active specific immunotherapy of residual micrometastasis: the acute and chronic inflammatory response in induction of tumor immunity by BCG-tumor cell immunization.
    Hanna MG; Bucana C
    J Reticuloendothel Soc; 1979 Oct; 26(4):439-51. PubMed ID: 513055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Obtaining active BCG substrains resistant to HINA].
    Gel'berg SI; Pozniak SB
    Probl Tuberk; 1976 Sep; (9):64-9. PubMed ID: 796848
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of isonicotinic acid hydrazide on the intratumor injection of BCG.
    Sparks FC; Albert NE; Breeding JH
    J Natl Cancer Inst; 1977 Feb; 58(2):367-8. PubMed ID: 319244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the vaccinating properties of BCG and its isoniazid-resistant mutant in guinea pigs.
    SCHAEFER WB; COHN ML; MIDDLEBROOK G
    Am Rev Tuberc; 1957 Apr; 75(4):656-8. PubMed ID: 13411425
    [No Abstract]   [Full Text] [Related]  

  • 19. Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.
    Peters LC; Hanna MG
    J Natl Cancer Inst; 1980 Jun; 64(6):1521-5. PubMed ID: 6990075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.